Alain Hanover, former managing director and head of Draper’s Navigator Technology Ventures, said: “I closed down Navigator.”
Month: April 2011
Alcatel-Lucent hires Max Straube
Max Straube is overseeing investments and will work with Bart Shigemura, head of Alcatel-Lucent Ventures.
HTC calls up OnLive
In a filing with the Taiwan Stock Exchange, HTC said it would buy 5.33 million shares in US-based OnLive at $7.50 per share as part of a partnership.
World opens for Gaia Online
News provider TechCrunch said the round took its total financing to more than $32m with investors including VC firms Benchmark Capital, DAG Ventures and Redpoint Ventures, and media groups Time Warner and Sony Pictures.?
Intel insured for ETechAces deal
ETechAces runs the PolicyBazaar.com insurance portal and has gained Intel Capital as an investor alongside Info Edge.
Motorola finds Scanbuy solution
Motorola Solutions Venture Capital backs latest $5m round for Scanbuy.
Chesapeake ups Frac Tech perccentage
Chesapeake has increased its stake in Frac Tech to 30% from 26%, newswire Reuters said, and it will gain a dividend from the buyout.
Future ventures to list this month
KK Rathi, chief executive of Future Ventures, said: “The idea is to invest in businesses that are strategically important for the overall group. We will be looking at acquiring, creating new and growing our existing private brands.”
IDG invests in China and India
US publisher International Data Group’s IDG Ventures India backs iProf Learning Solutions and IDG-Accel Capital invests in ShineOn.
Tracon swallows $22m in two bites
The first tranche for Tracon Pharmaceuticals is $14m to fund the development of the antibody TRC105 through its phase two trials.
Genzyme absent from Bluebird round
Third Rock led last year’s $35m B round that also saw biotech company Genzyme’s corporate venturing division join the investment consortium as a new investor and it remains on the company’s share register, although not publicly mentioned in its latest $30m C round.
Kobo reads up on $53m
Kobo said Indigo maintained its controlling position but existing investors, which also includes China’s Cheung Kong Holdings, provided C$13m of the total with the rest coming from a group led by an institutional investor.
Sagent raises $92m in flotation
Sagent Pharmaceuticals sold 5.75 million shares at $16 each, compared to plans to price five million shares at between $14 and $16 per share.
Reliance continues with exit successes
Reliance completes first US flotation from its portfolio, sells Pelago and sees investment in its Yatra.